Analysis of Latent Tuberculosis Infection Treatment Adherence Among Refugees and Other Patient Groups Referred to the Baltimore City Health Department TB Clinic, February 2009–March 2011

Journal of Immigrant and Minority Health

Volumn 17, Issue 1, 2015, Pages 56-65

  Nuzzo, Jennifer B ^a,b   Golub, Jonathan E ^c   Chaulk, Patrick ^d   Shah, Maunank ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BALTIMORE CITY HEALTH DEPARTMENT   (United States)

Author keywords

Diagnosis; Latent tuberculosis; Refugee; Treatment adherence; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMAN; LATENT TUBERCULOSIS; MALE; MARYLAND; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT REFERRAL; REFUGEE; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; BALTIMORE; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; REFERRAL AND CONSULTATION; REFUGEES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880743256     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-013-9882-9     Document Type: Article

References (16)

1. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:1–51.
2. Centers for Disease C, Prevention. Trends in tuberculosis—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:201–5.
3. LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis. 2010;14:1226–32.
4. Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, DellaLatta P, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med. 2002;346:1453–8.
5. Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011;364:1441–8.
6. CDC. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. In; 2010.
7. Cronin W. TB in Maryland: 2012 Epidemiologic Review. In: Talk presented at: Stop TB in my lifetime: meeting the challenge in Maryland meeting;. Clarksville, MD.
8. Hirsch-Moverman Y, Daftary A, Franks J, Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008;12:1235–54.
9. Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain ML, et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012;12:468.
10. Hirsch-Moverman Y, Bethel J, Colson PW, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis. 2010;14:1104–11.
11. Zuniga JA. Medication adherence in Hispanics to latent tuberculosis treatment: a literature review. J Immigr Minor Health. 2012;14:23–9.
12. Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14:e292–7.
13. Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8:711–7.
14. Trauer JM, Krause VL. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. Med J Aust. 2011;194:579–82.
15. Centers for Disease C, Prevention. Trends in tuberculosis—United States. MMWR Morb Mortal Wkly Rep. 2011;2012(61):181–5.
16. Trajman A, Long R, Zylberberg D, Dion MJ, Al-Otaibi B, Menzies D. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis. 2010;14:551–9.